GoodRx Holdings, Inc. (GDRX) Revenue Growth
GoodRx Holdings, Inc. (GDRX) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2021-12-31 | 35.36% |
| 2022-12-31 | 2.83% |
| 2023-12-31 | -2.12% |
| 2024-12-31 | 5.61% |
| 2025-12-31 | 0.57% |
How GDRX compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| ZTS | Zoetis Inc. Class A | 2.28% |
| IART | Integra LifeSciences Holdings Corporation | 1.53% |
| BIO | Bio-Rad Laboratories Inc. Class A | 0.65% |
| NEOG | Neogen Corporation | -2.71% |
| PRGO | Perrigo Company plc | -2.75% |
These are five companies in the same sector as GDRX with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get GoodRx Holdings, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("GDRX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | GDRX | $3.48 | -1.42% | 0.85M |
| 3 | ||||
| 4 | ||||
| 5 |